Uzm. Dr. Mert Kaşkal
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Hypertension 4 publicationsSource: OpenAlex / PubMed MeSHView publications
- Heart Failure 3 publications
- Cardiovascular Diseases 3 publications
- Atrial Fibrillation 2 publications
- Myocardial Infarction 2 publications
- COVID-19 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Pharmacologysaglik.gov.trFrom source
- InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workHypertensionExtracted from 4 publications · Model version —From source
- Publications42 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-2220-8529ORCIDFrom source
- Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393577/doktorlarimiz.html#mert-kaskalsaglik.gov.tr
Scientific work
Publications on Hypertension
-
Cytotoxic effect of famotidine in breast adenocarcinoma cells line
Northern Clinics of Istanbul, 2026
DOI 10.14744/nci.2026.55899 PMID 41940059 Open-access full textSource: OpenAlex
-
Cross-exclusion of patients with chronic obstructive pulmonary disease and heart failure in randomized controlled drug trials
Respiratory Medicine, 2026
DOI 10.1016/j.rmed.2026.108781 PMID 41862104 Source: ORCID
-
Albumin levels and risk of early cardiovascular complications after endovascular thrombectomy for acute ischaemic stroke
Scientific Reports, 2026
DOI 10.1038/s41598-026-50280-0 PMID 42032112 Open-access full textSource: ORCID
-
Long-term prognosis in Takotsubo syndrome compared to heart failure: observations from a global federated research network
ESC Heart Failure, 2026
DOI 10.1093/eschf/xvag065 PMID 41761829 2 citations (Europe PMC) Open-access full textSource: ORCID
-
Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network
BMC Pulmonary Medicine, 2026
DOI 10.1186/s12890-026-04216-z PMID 41782097 Open-access full textSource: ORCID
-
Prognostic Impact of New-Onset Atrial Fibrillation After Cardiac Arrest: Observations From a Federated Research Network
Journal of Cardiovascular Electrophysiology, 2026
DOI 10.1111/jce.70288 PMID 41668553 Open-access full textSource: ORCID
-
Additional file 2 of Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network
Figshare, 2026
DOI 10.6084/m9.figshare.31985912 Open-access full textSource: OpenAlex
-
Additional file 1 of Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network
Figshare, 2026
DOI 10.6084/m9.figshare.31985909 Open-access full textSource: OpenAlex
-
Additional file 6 of Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network
Figshare, 2026
DOI 10.6084/m9.figshare.31985924 Open-access full textSource: OpenAlex
-
Additional file 7 of Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network
Figshare, 2026
DOI 10.6084/m9.figshare.31985927 Open-access full textSource: OpenAlex